SenesTech (NASDAQ:SNES) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES) in a report released on Thursday morning. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright raised their price target on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.

SenesTech Stock Down 10.1 %

Shares of NASDAQ SNES opened at $1.47 on Thursday. The company has a current ratio of 6.32, a quick ratio of 4.92 and a debt-to-equity ratio of 0.05. SenesTech has a 12-month low of $1.36 and a 12-month high of $9.80. The firm’s 50-day moving average price is $2.69 and its 200-day moving average price is $2.73. The stock has a market capitalization of $2.57 million, a price-to-earnings ratio of -0.15 and a beta of -0.03.

SenesTech (NASDAQ:SNES) last issued its quarterly earnings data on Wednesday, March 12th. The company reported ($1.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.50) by $0.28. The business had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.71 million. SenesTech had a negative return on equity of 150.33% and a negative net margin of 403.51%. On average, equities research analysts anticipate that SenesTech will post -10.22 EPS for the current fiscal year.

SenesTech Company Profile

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.